More than 80 pharmaceutical companies have called on governments to develop new ways of paying them to develop antibiotics. With drug-resistant microbes predicted to kill 10 million people a year by 2050 and cost $100 trillion in lost economic output, Redx Pharm chief executive said “there is a doomsday clock ticking, with the effectiveness of antibiotics diminishing at an alarming rate, new ways must be found to support innovation and drug discovery in this critical area”.

EVIDENCIA CLÍNICA SYNOLIS VA®

CLÍNICA SYNOLIS VA® RENDIMIENTO  EN EL DOLOR Y...

La contaminación plástica puede estar extendiendo la resistencia a los antibióticos

Según una nueva investigación, compartida por la...

How India’s hospitals, rivers and chickens are driving global antibiotic resistance

A 59-year-old man from India, who was living in...

WHO’s ‘priority pathogens’ list highlights urgent need for new drugs

The World Health Organization has released its...

La resistencia a los antibióticos puede extenderse en ausencia de medicamentos.

Medical News Today informó recientemente sobre...

Gene-editing produces tenfold increase in superbug slaying antibiotics

ScienceDaily recently featured a study conducted...

¿Qué es la osteomielitis?

El Dr. Pablo S. Corona...

Distribuidor exclusivo.

0